Drugs / 1612 capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02982642 | Jan 2017 → Dec 2018 | cognitive impairment with or without cerebellar ataxia | Dongzhimen Hospital, Beijing | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1612 capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02982642 ↗ |